{"id":4013,"date":"2022-11-23T09:11:33","date_gmt":"2022-11-23T01:11:33","guid":{"rendered":"https:\/\/regask.com\/?p=4013"},"modified":"2024-10-26T03:03:37","modified_gmt":"2024-10-25T19:03:37","slug":"regeln-fur-klinische-arzneimittelstudien-in-indien","status":"publish","type":"post","link":"https:\/\/regask.com\/de\/india-drug-clinical-trial-rules\/","title":{"rendered":"Indien schl\u00e4gt \u00c4nderung der Vorschriften f\u00fcr neue Arzneimittel und klinische Studien vor \u2026"},"content":{"rendered":"<div>\n<p><a href=\"https:\/\/main.mohfw.gov.in\/\" target=\"_blank\" rel=\"noopener\">Das indische Ministerium f\u00fcr Gesundheit und Familienf\u00fcrsorge (MoHFW)<\/a> schlug eine \u00c4nderung der Regeln f\u00fcr neue Arzneimittel und klinische Studien (dritte \u00c4nderung) 2022 in Bezug auf Registrierungsformulare f\u00fcr neue Arzneimittel, neue APIs, klinische Studien und Bioverf\u00fcgbarkeits-\/Bio\u00e4quivalenzstudien in Bezug auf die zentrale Zulassungsbeh\u00f6rde vor.<\/p>\n<p>Dieser \u00c4nderungsantrag enth\u00e4lt die folgenden Formulare und die dazugeh\u00f6rigen Anweisungen:<\/p>\n<ul>\n<li>\u2026<\/li>\n<\/ul>\n<\/div>\n<div class=\"slider-wrapper relative\" id=\"slider-850631300\" >\n    <div class=\"slider slider-nav-circle slider-nav-large slider-nav-dark slider-style-normal\"\n        data-flickity-options='{            \"cellAlign\": \"center\",            \"imagesLoaded\": true,            \"lazyLoad\": 1,            \"freeScroll\": false,            \"wrapAround\": true,            \"autoPlay\": 4500,            \"pauseAutoPlayOnHover\" : true,            \"prevNextButtons\": true,            \"contain\" : true,            \"adaptiveHeight\" : true,            \"dragThreshold\" : 10,            \"percentPosition\": true,            \"pageDots\": false,            \"rightToLeft\": false,            \"draggable\": true,            \"selectedAttraction\": 0.1,            \"parallax\" : 0,            \"friction\": 0.6        }'\n        >\n        \n     <\/div>\n\n     <div class=\"loading-spin dark large centered\"><\/div>\n\n\t<\/div>\n\n\n\t<div id=\"gap-286312319\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-286312319 {\n  padding-top: 40px;\n}\n<\/style>\n\t<\/div>\n\t\n\n\t<section class=\"section\" id=\"section_1724364279\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row\"  id=\"row-1845267931\">\n\n\t<div id=\"col-159758665\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n\t<section class=\"section\" id=\"section_1789664744\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n\n<div class=\"row\"  id=\"row-1192455904\">\n\n\n\t<div id=\"col-545951328\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n<h2>Entschuldigung, dieser Premium-Inhalt ist nur f\u00fcr RegASK-Kunden.<\/h2>\n<p>M\u00f6chten Sie auf den gesamten Inhalt der Warnung zugreifen oder alle Nachrichten durchsuchen?\u00a0<\/p>\n<div class=\"row\"  id=\"row-911455566\">\n\n\n\t<div id=\"col-361275461\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n<a href=\"https:\/\/app.RegASK.com\/#\/\" target=\"_blank\" class=\"button secondary is-outline\" rel=\"noopener\" >\n\t\t<span>Kunden-Login<\/span>\n\t<\/a>\n\n\n<a href=\"https:\/\/regask.com\/de\/demo-anfordern\/\" class=\"button secondary lowercase\" style=\"border-radius:5px;\">\n\t\t<span>Demo buchen<\/span>\n\t<\/a>\n\n\n<a href=\"https:\/\/regask.com\/de\/more-insights\/\" target=\"_blank\" class=\"button secondary is-outline\" rel=\"noopener\" >\n\t\t<span>Durchsuchen Sie die Nachrichten<\/span>\n\t<\/a>\n\n\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1789664744 {\n  padding-top: 30px;\n  padding-bottom: 30px;\n  background-color: rgb(255,255,255);\n}\n<\/style>\n\t<\/section>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1724364279 {\n  padding-top: 30px;\n  padding-bottom: 30px;\n  background-color: rgb(0, 49, 117);\n}\n<\/style>\n\t<\/section>\n\t\n\t<div id=\"gap-285541113\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-285541113 {\n  padding-top: 60px;\n}\n<\/style>\n\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Das indische Ministerium f\u00fcr Gesundheit und Familienwohlfahrt (MoHFW) hat eine \u00c4nderung der \u201eNew Drugs and Clinical Trials (Third Amendment) Rules, 2022\u201c vorgeschlagen. Diese betrifft die Registrierungsformulare f\u00fcr neue Arzneimittel, neue Wirkstoffe, klinische Pr\u00fcfungen und Bioverf\u00fcgbarkeits-\/Bio\u00e4quivalenzstudien, die der Zentralen Zulassungsbeh\u00f6rde zugeordnet sind. Die \u00c4nderung sieht folgende Formulare und die dazugeh\u00f6rigen Anweisungen vor: \u2026<\/p>","protected":false},"author":39,"featured_media":3995,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[516,35],"tags":[40,56],"class_list":["post-4013","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-india-regulations","category-pharma-biotech-latest-insights","tag-latest-insights","tag-premium-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>India: Drug &amp; Clinical Trial Rules | RegASK<\/title>\n<meta name=\"description\" content=\"India proposes amendments to its New Drugs and Clinical Trials Rules. Stay updated on the latest regulations with RegASK.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/de\/regeln-fur-klinische-arzneimittelstudien-in-indien\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"India Proposed Amendment to New Drugs and Clinical Trials Rules\" \/>\n<meta property=\"og:description\" content=\"India proposes amendments to its New Drugs and Clinical Trials Rules. Stay updated on the latest regulations with RegASK.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/de\/regeln-fur-klinische-arzneimittelstudien-in-indien\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-23T01:11:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-25T19:03:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png\" \/>\n\t<meta property=\"og:image:width\" content=\"330\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/india-drug-clinical-trial-rules\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/india-drug-clinical-trial-rules\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"India Proposed Amendment to New Drugs and Clinical Tria&hellip;\",\"datePublished\":\"2022-11-23T01:11:33+00:00\",\"dateModified\":\"2024-10-25T19:03:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/india-drug-clinical-trial-rules\\\/\"},\"wordCount\":88,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/india-drug-clinical-trial-rules\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png\",\"keywords\":[\"Latest Insights\",\"Premium News\"],\"articleSection\":[\"India\",\"Pharma and Biotech\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/india-drug-clinical-trial-rules\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/india-drug-clinical-trial-rules\\\/\",\"name\":\"India: Drug & Clinical Trial Rules | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/india-drug-clinical-trial-rules\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/india-drug-clinical-trial-rules\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png\",\"datePublished\":\"2022-11-23T01:11:33+00:00\",\"dateModified\":\"2024-10-25T19:03:37+00:00\",\"description\":\"India proposes amendments to its New Drugs and Clinical Trials Rules. Stay updated on the latest regulations with RegASK.\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/india-drug-clinical-trial-rules\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/india-drug-clinical-trial-rules\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png\",\"width\":330,\"height\":300,\"caption\":\"India Proposed Amendment To New Drugs And Clinical Trials Rules\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\",\"https:\\\/\\\/www.crunchbase.com\\\/organization\\\/regask\",\"https:\\\/\\\/www.bloomberg.com\\\/profile\\\/company\\\/1691237D:SP\",\"https:\\\/\\\/pitchbook.com\\\/profiles\\\/company\\\/265004-02\",\"https:\\\/\\\/www.cbinsights.com\\\/company\\\/RegASK\",\"https:\\\/\\\/vimeo.com\\\/RegASK\"],\"legalName\":\"RegASK PTE. LTD.\",\"foundingDate\":\"2018\",\"slogan\":\"Empowering Smarter Regulatory Decisions\",\"description\":\"Agentic AI regulatory intelligence and workflow orchestration platform for Life Sciences and Consumer Products. RegASK combines vertical LLMs, multi-agent AI architecture, and a global community of 1,800+ subject matter experts to deliver regulatory horizon scanning, impact analysis, compliance workflow automation, and audit-ready outputs across 160+ countries.\",\"areaServed\":\"Worldwide\",\"founder\":{\"@type\":\"Person\",\"name\":\"Caroline Shleifer\",\"jobTitle\":\"Founder & CEO\"},\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"79 Science Park Drive, #06-01, Cintech IV\",\"addressLocality\":\"Singapore\",\"postalCode\":\"118264\",\"addressCountry\":\"SG\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+65 6817 6290\",\"contactType\":\"customer service\",\"availableLanguage\":[\"English\",\"French\",\"Japanese\",\"Spanish\",\"Chinese\",\"German\"]},\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":50,\"maxValue\":100},\"knowsAbout\":[\"Regulatory Intelligence\",\"Regulatory Compliance\",\"Regulatory Affairs\",\"Workflow Orchestration\",\"Life Sciences Regulation\",\"Consumer Products Regulation\",\"AI-Driven Compliance\"],\"hasCertification\":[{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 42001:2023\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27001:2022\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27701\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27018:2019\"},{\"@type\":\"Certification\",\"name\":\"SOC 2 Type II\"}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Indien: Vorschriften f\u00fcr Arzneimittel- und klinische Studien | RegASK","description":"Indien schl\u00e4gt \u00c4nderungen seiner Vorschriften f\u00fcr neue Arzneimittel und klinische Studien vor. Bleiben Sie mit RegASK \u00fcber die neuesten Vorschriften auf dem Laufenden.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/de\/regeln-fur-klinische-arzneimittelstudien-in-indien\/","og_locale":"de_DE","og_type":"article","og_title":"India Proposed Amendment to New Drugs and Clinical Trials Rules","og_description":"India proposes amendments to its New Drugs and Clinical Trials Rules. Stay updated on the latest regulations with RegASK.","og_url":"https:\/\/regask.com\/de\/regeln-fur-klinische-arzneimittelstudien-in-indien\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2022-11-23T01:11:33+00:00","article_modified_time":"2024-10-25T19:03:37+00:00","og_image":[{"width":330,"height":300,"url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Benoit Trouwaert","Est. reading time":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/india-drug-clinical-trial-rules\/#article","isPartOf":{"@id":"https:\/\/regask.com\/india-drug-clinical-trial-rules\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"India Proposed Amendment to New Drugs and Clinical Tria&hellip;","datePublished":"2022-11-23T01:11:33+00:00","dateModified":"2024-10-25T19:03:37+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/india-drug-clinical-trial-rules\/"},"wordCount":88,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/india-drug-clinical-trial-rules\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png","keywords":["Latest Insights","Premium News"],"articleSection":["India","Pharma and Biotech"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/regask.com\/india-drug-clinical-trial-rules\/","url":"https:\/\/regask.com\/india-drug-clinical-trial-rules\/","name":"Indien: Vorschriften f\u00fcr Arzneimittel- und klinische Studien | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/india-drug-clinical-trial-rules\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/india-drug-clinical-trial-rules\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png","datePublished":"2022-11-23T01:11:33+00:00","dateModified":"2024-10-25T19:03:37+00:00","description":"Indien schl\u00e4gt \u00c4nderungen seiner Vorschriften f\u00fcr neue Arzneimittel und klinische Studien vor. Bleiben Sie mit RegASK \u00fcber die neuesten Vorschriften auf dem Laufenden.","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/india-drug-clinical-trial-rules\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/india-drug-clinical-trial-rules\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png","width":330,"height":300,"caption":"India Proposed Amendment To New Drugs And Clinical Trials Rules"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Das regulatorische KI-Betriebssystem f\u00fcr leistungsstarke Teams","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK","https:\/\/www.crunchbase.com\/organization\/regask","https:\/\/www.bloomberg.com\/profile\/company\/1691237D:SP","https:\/\/pitchbook.com\/profiles\/company\/265004-02","https:\/\/www.cbinsights.com\/company\/RegASK","https:\/\/vimeo.com\/RegASK"],"legalName":"RegASK PTE. LTD.","foundingDate":"2018","slogan":"Empowering Smarter Regulatory Decisions","description":"Agentic AI ist eine Plattform f\u00fcr regulatorische Analysen und Workflow-Orchestrierung in den Bereichen Life Sciences und Konsumg\u00fcter. RegASK kombiniert vertikale LLMs, eine Multiagenten-KI-Architektur und eine globale Community von \u00fcber 1.800 Fachexperten, um regulatorische Zukunftsprognosen, Wirkungsanalysen, die Automatisierung von Compliance-Workflows und auditfertige Ergebnisse in \u00fcber 160 L\u00e4ndern bereitzustellen.","areaServed":"Worldwide","founder":{"@type":"Person","name":"Caroline Shleifer","jobTitle":"Founder & CEO"},"address":{"@type":"PostalAddress","streetAddress":"79 Science Park Drive, #06-01, Cintech IV","addressLocality":"Singapore","postalCode":"118264","addressCountry":"SG"},"contactPoint":{"@type":"ContactPoint","telephone":"+65 6817 6290","contactType":"customer service","availableLanguage":["English","French","Japanese","Spanish","Chinese","German"]},"numberOfEmployees":{"@type":"QuantitativeValue","minValue":50,"maxValue":100},"knowsAbout":["Regulatory Intelligence","Regulatory Compliance","Regulatory Affairs","Workflow Orchestration","Life Sciences Regulation","Consumer Products Regulation","AI-Driven Compliance"],"hasCertification":[{"@type":"Certification","name":"ISO\/IEC 42001:2023"},{"@type":"Certification","name":"ISO\/IEC 27001:2022"},{"@type":"Certification","name":"ISO\/IEC 27701"},{"@type":"Certification","name":"ISO\/IEC 27018:2019"},{"@type":"Certification","name":"SOC 2 Type II"}]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"Benoit Trouwaert"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/4013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/comments?post=4013"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/4013\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media\/3995"}],"wp:attachment":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media?parent=4013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/categories?post=4013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/tags?post=4013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}